Sterling Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$294K Sell
385
-25
-6% -$18.6K 0.09% 63
2025
Q2
$320K Sell
410
-2
-0.5% -$1.55K 0.11% 58
2025
Q1
$340K Buy
412
+33
+9% +$27.5K 0.12% 54
2024
Q4
$293K Buy
379
+13
+4% +$10.8K 0.11% 58
2024
Q3
$324K Buy
366
+5
+1% +$4.5K 0.14% 53
2024
Q2
$327K Hold
361
0.15% 52
2024
Q1
$281K Buy
361
+4
+1% +$2.85K 0.13% 54
2023
Q4
$208K Buy
+357
New +$208K 0.12% 58

Other funds holding LLY

Sterling Financial Group's LLY Position: Q3 2025 in Review

Sterling Financial Group reduced its Eli Lilly (LLY) stake by 6.1% in Q3 2025, selling an estimated $18.6K and leaving 385 shares worth $294K. The position accounts for 0.09% of the portfolio, ranked #63.

Sterling Financial Group first reported a position in LLY in Q4 2023 and has held it in 8 quarters since. The position peaked at $340K in Q1 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Sterling Financial Group held 385 shares of Eli Lilly worth $294K as of Q3 2025.
  • Sterling Financial Group sold 25 Eli Lilly shares in Q3 2025, an estimated $18.6K.
  • Eli Lilly made up 0.09% of Sterling Financial Group's portfolio in Q3 2025, its #63 holding.
  • Sterling Financial Group first reported a position in Eli Lilly in Q4 2023 and has held it in 8 quarters since.
  • Sterling Financial Group's Eli Lilly position peaked at $340K in Q1 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Sterling Financial Group's 13F filing for Q3 2025, filed 17 Nov 2025.